Clozapine is an antipsychotic medication with superior efficacy in treatment refractory schizophrenia. The molecular basis of clozapine's therapeutic profile is not well understood.
Introduction
Clozapine is an atypical antipsychotic medication that has superior therapeutic efficacy in treatment refractory schizophrenia (Kane et al., 1988; Kumra et al., 2008) . It has multiple side effects, including the development of metabolic syndrome and an elevated risk of agranulocytosis (Krupp and Barnes, 1992; Lamberti et al., 2006) . Though clozapine modu-lates various neurotransmitter receptors with inhibition constants (Ki) in the nanomolar range, the specific molecular mechanisms underlying clozapine's superior therapeutic actions and its particular side effect profile are not known (Brunello et al., 1995; Schotte et al., 1996) . C. elegans provides a tractable system that can be used to characterize targets and pathways affected by psychoactive drugs (Weinshenker et al., 1995; Bettinger et al., 2004) . Pathways originally described in C. elegans have been shown to underlie cellular mechanisms in mammalian biology (Horvitz and Sternberg, 1991; Hengartner and Horvitz, 1994; Fire et al., 1998; Horvitz, 1999; Ruvkun, 2001 ). Many behaviors under the control of the nervous system can be studied in C. elegans (Bargmann, 1998; Girard et al., 2005) . Studies in C. elegans have led to the identification of novel targets affected by the antidepressant fluoxetine (Choy and Thomas, 1999) , the antipsychotic clozapine (Karmacharya et al., 2009 ) and ethanol (Davies et al., 2003) . C. elegans is increasingly being used to study the biology underlying psychiatric neuroscience (Donohoe et al., 2008a (Donohoe et al., , 2008b Zubenko et al., 2009; Weeks et al., 2010) . Here, we investigated clozapine's effects on C. elegans behavior and systematically tested mutants with defects in biogenic amine neurotransmitter systems to identify novel pathways involved in clozapine's behavioral effects.
Effects observed in worms must subsequently be tested in mammalian systems to document their possible relevance in humans. Prepulse inhibition of acoustic startle (PPI) is an assay used in mammalian behavioral pharmacology to identify antipsychotics with therapeutic benefit (Geyer and Dulawa, 2003) . PPI is a reduction of whole-body startle magnitude occurring when the startling stimulus is preceded by a non-startling prestimulus. Clozapine is known to enhance PPI across species, in mice and healthy humans, as well as in the special case of people with schizophrenia ). We extended our findings from C. elegans to investigate whether pathways identified in C. elegans mediate clozapine-induced PPI enhancement in mice. If not, the actions might not be relevant to humans and might not deserve further study in efforts to understand the clinical effects of clozapine.
We report the discovery of interactions between clozapine and trace amine signaling in both C. elegans and mouse. Trace amines refer to the compounds tyramine, tryptamine, octopamine and β-phenylethylamine (β-PEA) that are present in 1000-fold lower concentrations than the classical biogenic amines, dopamine, norepinephrine and serotonin, in the mammalian brain (Branchek and Blackburn, 2003; Berry, 2004 Berry, , 2007 . Trace amines were previously thought to be byproducts of monoamines in the mammalian brain, but the discovery of specific trace amine receptors expressed in the human nervous system suggests that trace amines are signaling molecules in human brain (Borowsky et al., 2001) . Although trace amines have been implicated in the pathophysiology of mental illness (reviewed by Branchek and Blackburn, 2003) , no previous genetic evidence has linked trace amines to the biological effects of antipsychotic drugs. Therefore, our finding of interaction between clozapine and trace amine signaling may have implications for the therapeutic actions of clozapine and other antipsychotic drugs in human brain.
Results

Studies in C. elegans
2.1.1. Effect of clozapine on egg laying in C. elegans
Egg laying is a phenotype that has been extensively studied in C. elegans (Trent et al., 1983; Weinshenker et al., 1995; Schafer, 2006) . The neuropsychiatric drugs fluoxetine and imipramine, both antidepressants that modulate serotonin signaling, affect egg laying by a serotonergic mechanism (Dempsey et al., 2005) . We tested the effects of clozapine on egg laying at various time points (Fig. 1) . At 1.5 h, exposure to clozapine led to more than a two-fold increase in egg laying compared to controls. Over time, the effect of clozapine became more pronounced. After 5 h, animals exposed to clozapine displayed sustained increases in egg laying compared to animals under control conditions (Fig. 1) . We carried out a doseresponse study and found that clozapine increased egg laying in a dose-dependent manner (Fig. 2) . While clozapine is clinically unique in its superiority to other antipsychotics, it shares some biological effects with other antipsychotics. In order to determine whether clozapine's effect on egg laying behavior is recapitulated by other antipsychotic medications, we tested the first-generation, typical antipsychotic haloperidol and an atypical antipsychotic olanzapine. Although haloperidol and olanzapine also increased egg laying after an exposure of 1.5 h, the sustained increase in egg laying in response to clozapine was not observed with exposure to either haloperidol or olanzapine. There was no statistically significant difference in egg laying between haloperidol-exposed animals, olanzapine-exposed animals and control animals at the 3 h and 5 h time points Fig. 1 -Effects of different antipsychotics on egg laying. Mean number of eggs laid by gravid adult worms at different time points during exposure to a control condition of 1% ethanol, clozapine, haloperidol, and olanzapine. On average, control animals (n = 290) laid 2.3 ± 0.2 eggs at 3 h, whereas clozapine-exposed animals (n = 285) laid 5.6 ± 0.3 eggs at 3 h (p < 0.0001, unpaired t-test). On average, control animals (n = 290) laid 3.7 ± 0.2 eggs at 5 h, whereas clozapine-exposed animals (n = 285) laid 10.1 ± 0.4 eggs at 5 h (p < 0.0001, unpaired t-test). Haloperidol (n = 48) and olanzapine (n = 24) produced no effect at 3 and 5 h, even at the highest soluble doses that we could test, when compared to control. Error bars represent 1 SEM. * indicates p < 0.0001. (Fig. 1) . We also found that the clozapine metabolite Ndesmethyl-clozapine phenocopied the clozapine-induced increase in egg laying after 5 h (data not shown).
While noting the unique effect of clozapine on egg laying, we add a caveat that the concentrations of the three drugs are different due to the different solubility profiles of the drugs. Animals were exposed to the highest soluble level of the drugs in 1% ethanol-clozapine was used at 200 μg/ml, olanzapine at 100 μg/ml and haloperidol at 50 μg/ml. We note that, clinically, both haloperidol and olanzapine are used in human patients at doses (~10-20 mg/day) that are more than an order of magnitude lower than clozapine (~400 mg/day). Nonetheless, we found that clozapine's effect on egg laying was still observed at lower doses (Fig. 2) .
Effect of mutations in biogenic amine pathways on clozapine-induced egg laying
Since antipsychotics are known to affect signaling through multiple monoamines, including dopaminergic and serotonergic systems, we carried out a candidate gene screen in animals with mutations in genes required for these neurotransmitter systems (Table 1) . We tested whether any of these mutants suppressed clozapine-induced egg laying. The cat-2 gene encodes a tyrosine hydroxylase involved in the synthesis of dopamine (Lints and Emmons, 1999) . The tm2261 allele contains an out-of-frame deletion early in the coding sequence of cat-2 and therefore is likely to be a null. No dopamine is detectable in this strain by FIF assay (Sulston et al., 1975; National BioResource Project) . bas-1 encodes an aromatic amino acid decarboxylase, and mutations in this gene yield worms deficient in serotonin and dopamine (Loer and Kenyon, 1993) . The ad446 and tm351 alleles contain deletions in the coding sequence of bas-1 and are deficient in serotonin immunoreactivity (Hare and Loer, 2004) . tph-1 encodes tryptophan hydroxylase, which is necessary for serotonin biosynthesis. The tph-1(mg280) deletion mutant does not synthesize serotonin (Sze et al., 2000) . Clozapineinduced increases in egg laying were present in cat-2, bas-1 and tph-1 mutants (Fig. 3) . Failure of these mutants to block the clozapine-induced increase in egg laying suggests that neither serotonin nor dopamine is required for clozapine's effect on egg laying.
In the candidate gene screen, we were intrigued to find that a tdc-1 mutant showed no statistically significant increase in egg laying in response to clozapine compared to control conditions (Fig. 3) . tdc-1 worms contain a mutation in the tyrosine decarboxylase gene, which is required for the biosynthesis of tyramine and octopamine (Alkema et al., 2005) . TDC-1 is co-expressed with TBH-1 in RIC neurons and in gonadal sheath cells. The RICs are a pair of head interneurons in the lateral ganglion. Their processes enter the ventral cord and run anteriorly into the nerve ring where they form gap junctions with the ASH and AVK neurons. Synaptic inputs to the RICs come from the CEP, OLQ, URB, and URX neurons, while the principal synaptic outputs of the RICs are the AVA, SMD, and SMBD neurons (White et al., 1986) . TDC-1 is also expressed in the RIM neurons and uv1 cells that do not express TBH-1 (Alkema et al., 2005) . Tyramine may be released from uterine uv1 cells onto the vulva (Schafer, 2006) . The RIMs are a pair of motor neurons that modulate reversal behavior and that are required for suppression of head oscillations. The ALM/AVM sensory neurons are thought to stimulate tyramine release from the RIMs through activation of the AVA and AVD backward locomotion command neurons in response to anterior touch (Alkema et al., 2005) .
We repeated the egg laying study with a different allele of tdc-1 to confirm our original observation. Both tdc-1(ok914), a strain with a 629 bp deletion removing part of exon 4, all of Mean number of eggs laid by gravid adult worms with exposure to different doses of clozapine at 5 h. On average, control animals (n = 290) laid 3.7 ± 0.2 eggs, compared to 5.7 ± 0.9 eggs at 50 μg/ml (n = 20), 6.3 ± 0.7 eggs at 100 μg/ml (n = 20), 11.2 ± 0.9 eggs at 150 μg/ml (n = 20), and 10.1 ± 0.4 eggs at 200 μg/ml (n = 285). Error bars represent 1 SEM. * indicates p < 0.0001 (unpaired t-test).
Table 1 -C. elegans strains used in behavioral assays.
ser-2(pk1357) tyramine receptor exons 5 and 6, and part of exon 7, and tdc-1(n3149), with a 578 bp deletion removing part of exon 6 and all of exon 7 suppressed clozapine-induced egg laying (Fig. 4) . tdc-1, not bas-1, encodes the tyrosine decarboxylase required for the synthesis of both tyramine and octopamine, while tbh-1 encodes a tyramine β-hydroxylase gene that is required for octopamine biosynthesis (Alkema et al., 2005) . tdc-1 mutants block clozapine-induced egg laying (Figs. 3 and 4), but tbh-1 mutants do not (Fig. 3) , suggesting that this phenotype is mediated by tyramine, not octopamine. We tested a number of tyramine receptor mutants, including tyra-2, tyra-3, lgc-55, and ser-2 (Rex and Komuniecki, 2002; Tsalik et al., 2003; Rex et al., 2005; Wragg et al., 2007; Pirri et al., 2009; Ringstad et al., 2009 ) and observed no effects of these mutations on clozapine-induced egg laying (Fig. 3) . These results suggest that a currently unidentified tyramine receptor may mediate the effect of clozapine on egg laying. Alternatively, parallel pathways that employ different or multiple known receptors may mediate the effect of clozapine on egg laying. The increase in egg laying with clozapine was also not seen in egl-1(n487) or egl-1(n4065) mutants. On average (mean), egl-1 (n4065) worms exposed to clozapine laid only 6.0 ± 0.8 eggs (n = 21), which is similar to the 6.5 ± 0.8 eggs (n = 24) that egl-1 (n4065) worms laid under control conditions. In contrast, N2 worms exposed to clozapine laid an average of 10.1 ± 0.4 eggs (n = 285) compared to 3.7 ± 0.2 eggs under control conditions (n = 290). egl-1(gf) causes death of the HSN, the hermaphroditespecific neuron that drives egg laying. This result suggests that clozapine stimulates egg laying through the nervous system, rather than by stimulating the vulval muscle directly.
That tdc-1(lf) suppresses clozapine-induced egg laying indicates that the presence of tyramine is required for this phenotype and that clozapine may trigger egg laying by directly or indirectly stimulating tyramine release. We therefore performed q-RT-PCR experiments to test the effect of clozapine on tdc-1 expression. Clozapine induced a dramatic reduction of tdc-1 expression, suggesting a possible inhibitory feedback effect of clozapine-stimulated tyramine release on the expression of tdc-1 (Supplemental Fig. S1 ).
2.2.
Studies in mammals 2.2.1. Effect of clozapine on activity of mammalian TAARs TAAR1 in mice is a G protein-coupled receptor that activates adenylate cyclase. Therefore, we used a highly sensitive cAMP response element (CRE)-luciferase (Luc) assay to test whether clozapine as well as other antipsychotics can directly interact with mammalian TAARs. In our CRE-Luc assay, 1 μM clozapine did not change activity in TAAR1, TAAR3, TAAR5 or TAAR6 relative to baseline alone or when activated by forskolin (Supplemental Fig. S2 ). Nor was TAAR1 activity changed by 1 μM clozapine when activated by the TAAR1 agonists β-phenylethylamine (β-PEA) or methamphetamine Miller, 2008, 2009 ; data not shown). These results are congruent with and extend those of Bunzow et al. (2001) , who showed no antipsychotic-induced change in cAMP activation in cells transfected with rat TAAR1. Thus, we found no evidence that clozapine was a simple agonist or antagonist at the TAARs tested.
Studies of clozapine-induced PPI enhancement in wildtype and TAAR1 knockout mice
Using TAAR1 knockout mice, we tested the possibility that clozapine might have effects on a behavior mediated in part through TAAR1 (Wolinsky et al., 2007) . Results of our mouse behavioral studies implicate TAAR1 in the therapeutic enhancement of PPI by clozapine (Fig. 5 ). An omnibus ANOVA across all conditions (2 strains × 2 treatments × 2 repeatedmeasures of prepulse intensity) of the pre-vs. post-injection difference in percent PPI showed a significant strain x treatment interaction (F 1,45 = 4.4, p ≤ 0.04). Post hoc analyses within each strain showed that clozapine-treated wild-type mice exhibited significantly enhanced PPI after 3 days of clozapine exposure compared to vehicle-treated controls (F 1,23 = 13.8, p < 0.001), while TAAR1 knockout mice receiving clozapine failed to exhibit elevated %PPI after 3 days of treatment compared to vehicle-treated controls (F 1,22 = 0.3, p > 0.6). Knockout mice displayed somewhat elevated %PPI with respect to wild-type mice regardless of clozapine vs. vehicle treatment, suggesting that somewhat elevated PPI may be inherent to the knockout strain. Though the difference was not statistically significant, the failure of knockouts receiving clozapine to show elevated %PPI could conceivably have been due to a failure to elevate PPI above already high "baseline" levels. However, absolute %PPI values (Supplemental Fig. S3) show the typical monotonic increase in %PPI with prepulse level, indicating no such ceiling effect.
Discussion
The key mechanisms underlying clozapine's superior therapeutic effects and specific side effect profile remain unclear. A central challenge in advancing the treatment of schizophrenia is the identification of signaling pathways relevant to both the unique therapeutic and detrimental effects of clozapine. Characterizing these pathways might enable the identification of new compounds that possess clozapine's unique benefits but have a more favorable side effect profile. We undertook a study to identify novel pathways modulating clozapine-induced behavioral effects in C. elegans with subsequent follow-up of suggestive results in a mammalian system. We report heretofore-unrecognized interactions between antipsychotic medications and trace amine pathways in C. elegans and mice. The cloning of a family of G-protein-coupled trace amineassociated receptors (TAARs) found in the mammalian brain has led to resurgent interest in trace amines as neuromodulators and neurotransmitters (Borowsky et al., 2001; Premont et al., 2001; Grandy, 2007; Liberles and Buck, 2006; Sotnikova et al., 2009) . Abnormal levels of trace amines have been reported in schizophrenia and TAAR genes have been associated with susceptibility for schizophrenia and bipolar disorder in some reports (Potkin et al., 1979 (Potkin et al., , 1980 Branchek and Blackburn, 2003; Vladimirov et al., 2007; Pae et al., 2008a Pae et al., , 2008b . Some TAARs, including TAAR1, localize to rodent and primate amygdala (Xie et al., 2007; Lindemann et al., 2008) , a region shown to activate anomalously in mood and psychotic disorders. In addition, TAARs map to chromosome 6 in humans near a susceptibility locus for schizophrenia (Bunzow et al., 2001) .
We found that clozapine-induced increase in egg laying is suppressed in tdc-1 animals, which have a mutation in a tyrosine decarboxylase required for the synthesis of octopamine and tyramine (Alkema et al., 2005) . We followed the leads from our C. elegans studies to gain insight into the potential role played by signaling pathways activated by a trace amine receptor in clozapine's effects in mice. We assayed prepulse inhibition of acoustic startle because of its frequent use in mouse-based behavioral pharmacology of antipsychotics and its association with therapeutic benefit in patients with schizophrenia. Startle reactivity and the prepulse induced attenuation/inhibition of the startle response (PPI) are commonly used behavioral assays believed to reflect, in part, dopaminergic sensory motor gating of extraneous sensory information by forebrain structures in support of normal cognitive and motor function (Braff and Geyer, 1990; Swerdlow and Geyer, 1999) . Patients with schizophrenia exhibit weak PPI ) and show significant association of severity of psychotic symptoms with PPI impairment (Perry et al., 1999) . PPI improves in step with other symptoms in patients on antipsychotic treatment and is a routinely used assay to screen new drugs for possible antipsychotic benefit (Geyer and Dulawa, 2003) . We used PPI to examine the role of trace amine signaling in the therapeutic action of clozapine and discovered that TAAR1 knockout mice do not exhibit clozapine-induced enhancement of PPI. While this abnormality may be due to developmental or compensatory changes in the knockout mice, our findings nevertheless suggest that clozapine may enhance PPI in mice through modulation of TAAR1-mediated signaling pathways.
Our results indicate that clozapine interacts with trace amine-mediated pathways to affect behaviors in C. elegans and that the TAAR1 receptor many be involved in the enhanced PPI response to clozapine in mice. What is common in the results Fig. 5 -Effect of TAAR1 mutations on clozapine-induced PPI enhancement. Mean of the within-subject before-and after-treatment differences in startle amplitude is plotted over three prepulse levels for TAAR1 knockout and wild-type mice. Error bars represent 1 SEM. * denotes p < 0.001. from both nematode and mouse is that functional trace amine signaling must be present for clozapine to produce the behavioral effects we measured. Since our data show minimal effects of clozapine in the activity of TAAR reporter lines, we speculate that clozapine's modulation of trace amine signaling in mice does not occur directly at the receptor itself. It is possible, of course, that clozapine interacts with TAAR1 in a fashion that is not observed with the assays commonly used to detect agonists or antagonists.
Our data suggest an intriguing mechanism of clozapine action using behavioral genetic screening in a nematode followed up in mice. However, there are limitations to generalization of results from C. elegans and rodents to humans. While many genes are conserved between nematodes and mammals, the similarities and differences in the binding sites for neurotransmitters and small molecules across species are not known in detail. Moreover, at this time we cannot distinguish whether clozapine-induced behaviors are a direct result of clozapine's effects on trace amine signaling or whether other events occurring during clozapine exposure affect these behaviors, with trace amine signaling playing a permissive role. We also note that clear TAAR orthologs have not been identified in C. elegans based on overall sequence homology, though this does not rule out the possibility that such orthologs exist (Gloriam et al., 2005; Lindemann et al., 2005; Hashiguchi and Nishida, 2007; Hussain et al., 2009 ). For example, conservation of a small number of key residues can be sufficient for orthology, as in the case of cep-1, the C. elegans p53 ortholog (Derry et al., 2001) . Similarly, it remains unclear whether mammalian homologs for invertebrate trace amine receptors exist, but this field is in rapid flux (Branicky and Schafer, 2009; Pirri et al., 2009; Ringstad et al., 2009) . Another caveat in these studies is that exogenous application of drugs to C. elegans makes accurate control of tissue levels difficult. However, we have measured levels of clozapine in the tissue of worms exposed to clozapine and have found that the tissue level in C. elegans is in the same range (~18 mg/ml) as expected in the brains of humans patients (~11 mg/ml) (Karmacharya et al., 2009) . Another important limitation in our approach is that the TAAR1 knockout mouse strain is not a conditional knockout. TAAR1 knockout mice exhibit potentially important differences relative to wild-type besides the lack of the target receptor. For example, D2 receptor density in the striatum is 2.6 times higher in TAAR1 knockout mice than in wild-type mice (Wolinsky et al., 2007) . Though clozapine binds the D2 receptor weakly, our results must be interpreted in the context of these differences, inherent to the use of knockout technologies (Kapur et al., 1999; Gardner et al., 2005) . Future studies using a recently discovered TAAR1 antagonist (Bradaia et al., 2009) could resolve this question.
With these notes of caution, we raise the possibility that antipsychotic drugs may exert some of their therapeutic effects in the human brain through modulation of trace amine systems. While there is some evidence linking trace amine signaling to the pathogenesis of schizophrenia, we believe that our report is the first to link the biological effects of antipsychotic drugs to trace amine signaling. Further exploration of the role of the trace amine systems in the pathophysiology and treatment of schizophrenia could lead to new and improved approaches to therapeutic intervention.
4.
Experimental procedures
C. elegans strains
Most of the strains used in this study were obtained from the Caenorhabditis Genetics Center (CGC) in Minneapolis, MN (Table 1) . C. elegans Bristol strain N2 was used as the wild-type parent of our mutant strains. MT9455 tbh-1(n3247), GR1321 tph-1 (mg280), DA1814 ser-1(ok345), FX01815 tyra-2(tm1815) and QW89 lgc-55(tm2913) were gifts from Dr. Mark Alkema (University of Massachusetts Medical Center, Worcester, MA). FX01062 dop-2 (tm1062), FX02261 cat-2(tm2261) and FX01846 tyra-2(tm1846) were contributed by Dr. Shohei Mitani (National BioResource Project, Tokyo, Japan). The backcrossed tyra-3 strain was contributed by Dr. Richard Komuniecki (University of Toledo, Toledo, OH). We backcrossed the tdc-1 (ok914) strain to the N2 strain seven times and backcrossed the dop-2(tm1062) strain to the N2 strain six times. We obtained clozapine and haloperidol from Sigma-Aldrich and olanzapine from Waterstone Technology. Nematodes were grown and studied under standard culture conditions at 20°C unless otherwise noted.
Egg laying assay
We used staged worms 24 h post-L4. Clozapine, olanzapine and haloperidol were dissolved in ethanol at the highest concentrations possible, 20 mg/ml, 10 mg/ml and 5 mg/ml, respectively, because the collagen cuticle of C. elegans forms a strong barrier to exogenously applied compounds. We conducted egg laying assays in 96-well microtiter plates. Each well contained 100 μl M9 solution with 200 μg/ml of clozapine, 100 μg/ml of olanzapine, 50 μg/ml of haloperidol or 1% ethanol (vehicle). One young adult worm was picked to an unseeded NGM plate and allowed to move away from the bacteria, then transferred to a well containing drug solution or control solution. The number of eggs laid was counted at 1.5, 3, and 5 h.
Quantitative RT-PCR
Worms 24 h post-L4 were placed on NGM plates containing 200 μg/ml clozapine or 1% DMSO plates. The worms were collected after 5 h and RNA extracted by a standard Trizolbased protocol. After purification, cDNA was obtained from 1 to 2 μg mRNA by SuperScrpt® III Kit (Invitrogen, CA, USA). Real-time PCR were performed using these cDNAs as templates on MJ Research Opticon 2 System (BioRad, USA) with SYBR® Green qPCR reagents (Invitrogen, CA, USA). RT-PCR data were interpreted using the delta delta CT (2 −ΔΔCT ) method to quantitate the relative change in tdc-1 expression, using actin-1 as a reference gene.
4.4.
Cell line studies
The HEK293 cell culture and transfection experiments were performed according to the procedures of Xie et al. (2007) . HEK293 cells were transiently transfected with pcDNA 3.1 (+), rhesus monkey trace amine-associated receptor 1 (TAAR1), TAAR3, TAAR5 or TAAR6 along with CRE-Luc and pGL4.73 to generate cell lines: HEK, TAAR1, TAAR3, TAAR5 and TAAR6. Following transfection incubation (12 h), the cells were exposed to 1 μM of each drug (clozapine, olanzapine, perphenazine, haloperidol, forskolin, or methamphetamine) for 18 h in serumfree medium under growth conditions. To evaluate the influence of antipsychotics on activated TAARs, CRE-Luc expression was measured when these cell lines were exposed to vehicle or 1 μM of each drug in serum-free medium 5 min before and during 18 h incubation with 1 μM forskolin, 1 μM β-PEA, or 1 μM methamphetamine. Three independent experiments were performed in triplicate for each condition.
Mice
A strain of mice engineered to lack the TAAR1 receptor has been developed and characterized (Wolinsky et al., 2007 
Drug dosing
Mice received once-daily IP injection of 4 mg/kg clozapine or vehicle for 3 days (after Zarate et al., 2004) . Clozapine was dissolved in 2 N HCl, brought to target volume with 0.9% saline, and to pH~7 with 1 N NaOH.
Prepulse inhibition
PPI experiments were conducted in a single SR-LAB mouse startle chamber (San Diego Instruments, San Diego, CA). We used PPI parameters used in the original study that characterized behavioral phenotypes of the TAAR1 knockout strain: 10 min acclimation to the startle chamber in the presence of 70 dB background noise; 20 ms prepulses 2, 4, or 8 dB above background preceding a 40 ms, 120 dB startle by 100 ms (Wolinsky et al., 2007) . Fifty-six pseudo-randomized trials comprised prepulse-with-startle, prepulse-alone, startlealone, and background-alone trials with a 15 s variable intertrial interval. We applied these parameters to a 3-day clozapine administration protocol (Zarate et al., 2004) to examine within-subject change in PPI for clozapine vs. vehicle-treated knockout and wild-type mice. On day 1, mice were tested prior to injection, on day 2 mice received injections only, and on day 3 mice were tested 1 h postinjection. All groups were equated for mean startle-alone (F 3,45 = 0.9, p > 0.5) and day 1 PPI amplitudes (F 3,45 = 0.2-0.5, p > 0.7).
Statistical analysis
For the C. elegans studies, data are expressed as means ±S.E.M. Statistical comparisons were performed using the unpaired, twotailed Student's t-test. For the cell line studies, data were analyzed by ANOVA with Bonferroni adjustment. For the mouse PPI experiments, we used a mixed model ANOVA across conditions (2 strains× 2 treatments ×2 repeated-measures of prepulse intensity) to compare the pre-vs. post-injection difference in percent PPI. Stiernagle at the C. elegans Genetics Center and the National BioResource Project (Tokyo, Japan) for worm strains used in this work.
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